Pages that link to "Q50525085"

The following pages link to Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers (Q50525085):

Displaying 18 items.

• Natural product-based amyloid inhibitors. (Q38733078) (← links)
• Preventive Effect of Rifampicin on Alzheimer Disease Needs at Least 450 mg Daily for 1 Year: An FDG-PET Follow-Up Study (Q40142384) (← links)
• Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A2 in a spatial-specific manner (Q41149645) (← links)
• Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer's disease: analysis of Osaka mutation-knockin mice (Q41195874) (← links)
• Assessment of Autophagy in Neurons and Brain Tissue (Q41664421) (← links)
• A Near-Infrared Responsive Drug Sequential Release System for Better Eradicating Amyloid Aggregates. (Q46287826) (← links)
• The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade. (Q54977832) (← links)
• Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing (Q57647180) (← links)
• Repurposing Proteostasis-Modifying Drugs to Prevent or Treat Age-Related Dementia: A Systematic Review (Q58697971) (← links)
• Study of tau pathology in male rTg4510 mice fed with a curcumin derivative Shiga-Y5 (Q60046287) (← links)
• Intranasal rifampicin for Alzheimer's disease prevention. (Q64932512) (← links)
• Pharmacological Potential of Cilostazol for Alzheimer's Disease. (Q64950267) (← links)
• Proposing BCG Vaccination for Mycobacterium avium ss. paratuberculosis (MAP) Associated Autoimmune Diseases (Q89598499) (← links)
• APP Osaka Mutation in Familial Alzheimer's Disease-Its Discovery, Phenotypes, and Mechanism of Recessive Inheritance (Q89861110) (← links)
• Coniferaldehyde attenuates Alzheimer's pathology via activation of Nrf2 and its targets (Q92423968) (← links)
• Osmolytes: A Possible Therapeutic Molecule for Ameliorating the Neurodegeneration Caused by Protein Misfolding and Aggregation (Q92663099) (← links)
• Chronic Inflammatory Diseases at Secondary Sites Ensuing Urogenital or Pulmonary Chlamydia Infections (Q92810919) (← links)
• Treating psychiatric symptoms and disorders with non-psychotropic medications (Q95579830) (← links)